Perspective Therapeutics (CATX) Income from Continuing Operations (2016 - 2025)
Historic Income from Continuing Operations for Perspective Therapeutics (CATX) over the last 16 years, with Q3 2025 value amounting to -$26.0 million.
- Perspective Therapeutics' Income from Continuing Operations fell 7172.99% to -$26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$109.4 million, marking a year-over-year decrease of 7404.04%. This contributed to the annual value of -$81.4 million for FY2024, which is 7497.2% down from last year.
- According to the latest figures from Q3 2025, Perspective Therapeutics' Income from Continuing Operations is -$26.0 million, which was down 7172.99% from -$22.0 million recorded in Q2 2025.
- In the past 5 years, Perspective Therapeutics' Income from Continuing Operations ranged from a high of $1.3 million in Q2 2021 and a low of -$43.2 million during Q4 2024
- Its 5-year average for Income from Continuing Operations is -$11.2 million, with a median of -$10.4 million in 2023.
- Its Income from Continuing Operations has fluctuated over the past 5 years, first soared by 21329.97% in 2021, then tumbled by 308733.15% in 2024.
- Quarter analysis of 5 years shows Perspective Therapeutics' Income from Continuing Operations stood at -$1.6 million in 2021, then crashed by 357.29% to -$7.3 million in 2022, then crashed by 236.4% to -$24.7 million in 2023, then plummeted by 75.14% to -$43.2 million in 2024, then soared by 39.91% to -$26.0 million in 2025.
- Its Income from Continuing Operations stands at -$26.0 million for Q3 2025, versus -$22.0 million for Q2 2025 and -$18.2 million for Q1 2025.